Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| TNF- Signaling in Noise Trauma-Induced PV Neuron Loss and Dysfunction | Grant | $422,125.00 | Research | Shaowen Bao | Physiology | National Institute on Deafness and Other Communication Disorders | 03/2023 |
| PVAHCS - IPA for Lauren Herrmann (PI: Karen Hastings MD, PhD) | Contract | $65,822.50 | Research | Karen Hastings | COM Phx Basic Medical Sci | Phoenix VA Health Care System | 03/2023 |
| National Coordinating Site for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers (RTCCs) | Cooperative Agreement | $127,000.00 | Research | Christopher Banek | Physiology | University of Maryland | 03/2023 |
| Miniscope in vivo imaging of cumulative traumatic brain injury | Grant | $422,125.00 | Research | Jonathan Lifshitz | COM Phx Child Health | National Institute of Neurological Disorders and Stroke | 03/2023 |
| Discovery of Novel Genetic Variations in Cerebral Palsy by Whole Genome Sequencing | Grant | $28,520.00 | Research | Michael Kruer | COM Phx Child Health | Washington University in St. Louis | 03/2023 |
| Development of a DEAD Box Helicase UAP56 Specific RNA Aptamer for Cancer Therapy | Grant | $225,000.00 | Research | Shalini Sharma | COM Phx Basic Medical Sci | Arizona Biomedical Research Centre | 03/2023 |
| Cut and Paste of Myosin Binding Protein-C in Skeletal Muscles | Grant | $371,470.00 | Research | Samantha Harris | Cellular & Molecular Medicine | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 03/2023 |
| Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR) | Cooperative Agreement | $31,792.00 | Research | Geoffrey Gurtner | Surgery | University of Southern California | 03/2023 |
| Biomarkers of Disrupted Folate Metabolism: Risk Factors for Autism and Pregnancy Complications, Identifying Avenues for Prevention | Grant | $724,750.00 | Research | Richard Frye | COM Phx Child Health | Arizona Biomedical Research Centre | 03/2023 |
| Abuse and Neglect Prevention Surveys 2.0 | Contract | $31,917.00 | Research | Wendy Parent-Johnson | Family and Community Medicine | Arizona Health Care Cost Containment System | 03/2023 |
| 2023 Weston Advisor Agreement - Tariot | Contract | $9,134.06 | Research | Pierre Tariot | COM Phx Psychiatry | Weston Family Foundation (Canada) | 03/2023 |
| Arizona First Responders Comprehensive Addiction Recovery | Grant | $1,346,747.00 | Other Sponsored Activity | Joshua Gaither | Dept of Emergency Medicine | Arizona Department of Health Services | 03/2023 |
| Student Aid for Field Epidemiology Response - Pinal County | Contract | $580,000.00 | Instruction | Kristen Pogreba Brown | Epidemiology and Biostatistics | Pinal County, Arizona | 03/2023 |
| Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe) | Contract | $568,247.00 | Clinical Trial | Aaron Scott | Cancer Center Division | Leap Therapeutics, Inc. | 03/2023 |
| REMODEL - Renal Mode Of Action Of Semaglutide In Patients With Type 2 Diabetes And Chronic Kidney Disease | Contract | $161,045.72 | Clinical Trial | Frank Brosius III | Medicine | Novo Nordisk, Inc. | 03/2023 |
| Pediatric Acute Leukemia (PedAL) Screening Trial Developing New Therapies for Relapsed Leukemias. A Leukemia & Lymphoma Society and COG Groupwide Screening Protocol | Contract | $47,000.00 | Clinical Trial | Holly Pariury | Cancer Center Division | Public Health Institute | 03/2023 |
| IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hyper | Contract | $288,183.00 | Clinical Trial | Franz Rischard | Medicine | Aerovate Therapeutics | 03/2023 |
| Flow Regulation by Opening the Septum in Patients with Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study | Contract | $514,962.00 | Clinical Trial | Arka Chatterjee | Medicine | Occlutech US LLC (Switzerland) | 03/2023 |
| CHIPS (CHIlled Platelet Study) Is a Phase III, Multicenter, Randomized, Double-Blinded, Adaptive, Non-Inferiority, Storage Duration Ranging Trial in Adult and Pediatric Patients Undergoing Cardiac Sur | Contract | $311,500.00 | Clinical Trial | Toshinobu Kazui | Surgery | University of Pittsburgh | 03/2023 |
| Assessment of Implantable CCM in the Heart Failure Group with Higher Ejection FRaction | Contract | $178,782.00 | Clinical Trial | Radha Gopalan | COM Phx Internal Medicine | Impulse Dynamics (USA) Inc. | 03/2023 |
| A Second Randomized Controlled Trial of Alternating Irrigation of Vancomycin Hydrochloride and Tobramycin Sulfate in Patients Undergoing Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infect | Contract | $195,979.00 | Clinical Trial | Joseph Walker | COM Phx Internal Medicine | Osteal Therapeutics | 03/2023 |
| A Phase 3, Reandomized, Double-blind, Controlled Study Evaluating the Efficacy oand Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for F508del, Heterozygous f | Contract | $741,106.20 | Clinical Trial | Cori Daines | Asthma/Airway Disease Rsch Ctr | Vertex Pharmaceuticals, Incorporated | 03/2023 |
| A Phase 3, Prospective, Randomized, Open-label, AdaptiveGroup Sequential, Multicenter Trial with Blinded EndpointAssessment to Evaluate the Efficacy and Safety ofPROTHROMPLEX TOTAL for the Reversal of | Contract | $143,902.00 | Clinical Trial | Michael Ditillo | Surgery | Takeda Pharmaceuticals U.S.A., Incorporated | 03/2023 |
| A Phase 1/1b Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of KIN-3248 in Participants with Advanced Tumors Harbori | Contract | $216,243.00 | Clinical Trial | Aaron Scott | Cancer Center Division | Kinnate Biopharma Inc | 03/2023 |
| Mapping the Structure and Interaction of Mybp-c and Myosin in Hypertrophic Cardiomyopathy | Fellowship | $65,106.00 | Research Training | Fiona Wong | Cellular & Molecular Medicine | American Heart Association, Incorporated | 02/2023 |